Quantcast
Home > Quotes > LPTX

Leap Therapeutics, Inc. Common Stock (LPTX) Quote & Summary Data

LPTX 
$1.55
*  
unch
unch
Get LPTX Alerts
*Delayed - data as of Jun. 19, 2019  -  Find a broker to begin trading LPTX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 1.60 / $ 1.52
Share Volume
107,222
50 Day Avg. Daily Volume
226,921
Previous Close
$ 1.55
52 Week High / Low
$ 9.45 / $ 1.35
Market Cap
35,571,049
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
107,222
50 Day Avg. Daily Volume:
226,921

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.42

Trading Range

The current last sale of $1.55 is 14.81% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.60 $ 9.45
 Low: $ 1.52 $ 1.35

Company Description (as filed with the SEC)

We were incorporated in the state of Delaware as Dekkun Corporation on January 3, 2011 and changed our name to HealthCare Pharmaceuticals, Inc. effective May 29, 2014, and then to Leap Therapeutics, Inc. effective November 16, 2015. During 2015, HealthCare Pharmaceuticals Pty Ltd ("HCP Australia") was formed and is our wholly owned subsidiary. On December 10, 2015, we entered into a merger agreement with GITR Inc. ("GITR"), an entity under common control, whereby a wholly owned subsidiary was merged with GITR and the surviving name of the wholly owned subsidiary was GITR Inc. On August 29, 2016, we entered into a definitive merger agreement with Macrocure Ltd. ("Macrocure"), a publicly held, clinical-stage biotechnology company based in Petach Tikva, Israel, and M-Co Merger Sub Ltd.  ... More ...  



Risk Grade

Where does LPTX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.53
Open Date:
Jun. 19, 2019
Close Price:
$ 1.55
Close Date:
Jun. 19, 2019


Consensus Recommendation

Analyst Info